BDX250117C335000
- 0.00
- 0.000.00%
Becton Dickinson & Co Newsroom
Unusual Options Activity: NVDA, BIDU and Others Attract Market Bets, NVDA V/OI Ratio Reaches 3000.0
EST Jan 24th Closing Delivery - In the last three hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options
BD Stock Rises on Biosero Deal for AI-Powered Robotic Cytometry Tech
5 S&P 500 Stocks Set To Shine In The Final Week Of January — If History Repeats Itself
BD and Biosero Collaborate to Enable Robotic Integration With Flow Cytometers Used in Drug Discovery and Development
Carilion Clinic In Partnership With Becton, Dickinson And Company Announced That Carilion Is The First Health System In The State And The Southeastern U.S. To Provide Its Patients Needle-free Blood Draws Using The BD PIVO Pro Needle-free Blood...
Express News | BD : Barclays Cuts Target Price to $278 From $312
Carilion Clinic First in Virginia to Offer Needle-free In-patient Blood Draws, Redefining Patient Standard of Care
Barclays Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Maintains Target Price $278
Barclays Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Cuts Target Price to $278
Barclays Adjusts Becton, Dickinson and Company Price Target to $278 From $312, Maintains Overweight Rating
Becton, Dickinson and Company's (NYSE:BDX) Has Had A Decent Run On The Stock Market: Are Fundamentals In The Driver's Seat?
Price Over Earnings Overview: Becton Dickinson
(BDX) - Analyzing Becton Dickinson's Short Interest
BD to Announce Financial Results for Its First Quarter of Fiscal 2025
These 4 Measures Indicate That Becton Dickinson (NYSE:BDX) Is Using Debt Reasonably Well
Is Becton, Dickinson and Company (BDX) an Undervalued Stock?
Becton Dickinson Ramps Ups Medical Device Production for FY25
Becton, Dickinson And Company Says It Boosts US Manufacturing Of Critical Medical Devices: Among Others Company Plans Over $30M In Investments In 2025 To Expand Manufacturing Capacity For IV Lines At Its Plant In Utah To Support Continued Growth In...
Express News | BD: New Needle, Syringe Production Lines Installed at BD Plants in Connecticut and Nebraska
Express News | BD: Plans for More Than $30 Mln Investments in 2025 to Expand Manufacturing Capacity for IV Lines at Utah Plant